Global Anti-CD20 Monoclonal Antibodies Market Insights and Forecast to 2028

Global Anti-CD20 Monoclonal Antibodies Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Anti-CD20 Monoclonal Antibodies Product Introduction
1.2 Market by Type
1.2.1 Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 First Generation Anti-CD20 Monoclonal Antibody
1.2.3 Second Generation Anti-CD20 Monoclonal Antibody
1.2.4 Third Generation Anti-CD20 Monoclonal Antibody
1.3 Market by Application
1.3.1 Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Immunology
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-CD20 Monoclonal Antibodies Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-CD20 Monoclonal Antibodies Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-CD20 Monoclonal Antibodies Sales by Region
2.4.1 Global Anti-CD20 Monoclonal Antibodies Sales by Region (2017-2022)
2.4.2 Global Sales Anti-CD20 Monoclonal Antibodies by Region (2023-2028)
2.5 Global Anti-CD20 Monoclonal Antibodies Revenue by Region
2.5.1 Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2017-2022)
2.5.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-CD20 Monoclonal Antibodies Sales by Manufacturers
3.1.1 Global Top Anti-CD20 Monoclonal Antibodies Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-CD20 Monoclonal Antibodies in 2021
3.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Manufacturers
3.2.1 Global Anti-CD20 Monoclonal Antibodies Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-CD20 Monoclonal Antibodies Revenue in 2021
3.3 Global Anti-CD20 Monoclonal Antibodies Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-CD20 Monoclonal Antibodies Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-CD20 Monoclonal Antibodies Sales by Type
4.1.1 Global Anti-CD20 Monoclonal Antibodies Historical Sales by Type (2017-2022)
4.1.2 Global Anti-CD20 Monoclonal Antibodies Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2017-2028)
4.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Type
4.2.1 Global Anti-CD20 Monoclonal Antibodies Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-CD20 Monoclonal Antibodies Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
4.3 Global Anti-CD20 Monoclonal Antibodies Price by Type
4.3.1 Global Anti-CD20 Monoclonal Antibodies Price by Type (2017-2022)
4.3.2 Global Anti-CD20 Monoclonal Antibodies Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-CD20 Monoclonal Antibodies Sales by Application
5.1.1 Global Anti-CD20 Monoclonal Antibodies Historical Sales by Application (2017-2022)
5.1.2 Global Anti-CD20 Monoclonal Antibodies Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2017-2028)
5.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Application
5.2.1 Global Anti-CD20 Monoclonal Antibodies Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-CD20 Monoclonal Antibodies Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
5.3 Global Anti-CD20 Monoclonal Antibodies Price by Application
5.3.1 Global Anti-CD20 Monoclonal Antibodies Price by Application (2017-2022)
5.3.2 Global Anti-CD20 Monoclonal Antibodies Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-CD20 Monoclonal Antibodies Market Size by Type
6.1.1 North America Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
6.1.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
6.2 North America Anti-CD20 Monoclonal Antibodies Market Size by Application
6.2.1 North America Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
6.2.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
6.3 North America Anti-CD20 Monoclonal Antibodies Market Size by Country
6.3.1 North America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2028)
6.3.2 North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-CD20 Monoclonal Antibodies Market Size by Type
7.1.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
7.1.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
7.2 Europe Anti-CD20 Monoclonal Antibodies Market Size by Application
7.2.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
7.2.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
7.3 Europe Anti-CD20 Monoclonal Antibodies Market Size by Country
7.3.1 Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2028)
7.3.2 Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Size by Type
8.1.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Size by Application
8.2.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Size by Region
8.3.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-CD20 Monoclonal Antibodies Market Size by Type
9.1.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
9.1.2 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
9.2 Latin America Anti-CD20 Monoclonal Antibodies Market Size by Application
9.2.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
9.2.2 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
9.3 Latin America Anti-CD20 Monoclonal Antibodies Market Size by Country
9.3.1 Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2028)
9.3.2 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Size by Type
10.1.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Size by Application
10.2.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Size by Country
10.3.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Genmab
11.1.1 Genmab Corporation Information
11.1.2 Genmab Overview
11.1.3 Genmab Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Genmab Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Genmab Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Celltrion
11.3.1 Celltrion Corporation Information
11.3.2 Celltrion Overview
11.3.3 Celltrion Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Celltrion Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celltrion Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Overview
11.4.3 Roche Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Roche Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Corporation Information
11.5.2 Novartis AG Overview
11.5.3 Novartis AG Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis AG Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis AG Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Biogen
11.7.1 Biogen Corporation Information
11.7.2 Biogen Overview
11.7.3 Biogen Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biogen Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biogen Recent Developments
11.8 Genentech
11.8.1 Genentech Corporation Information
11.8.2 Genentech Overview
11.8.3 Genentech Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genentech Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genentech Recent Developments
11.9 Immunomedics
11.9.1 Immunomedics Corporation Information
11.9.2 Immunomedics Overview
11.9.3 Immunomedics Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Immunomedics Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Immunomedics Recent Developments
11.10 Spectrum Pharmaceuticals
11.10.1 Spectrum Pharmaceuticals Corporation Information
11.10.2 Spectrum Pharmaceuticals Overview
11.10.3 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Spectrum Pharmaceuticals Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Corporation Information
11.11.2 Bio-Rad Laboratories Overview
11.11.3 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bio-Rad Laboratories Recent Developments
11.12 LFB Biotechnologie
11.12.1 LFB Biotechnologie Corporation Information
11.12.2 LFB Biotechnologie Overview
11.12.3 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 LFB Biotechnologie Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-CD20 Monoclonal Antibodies Industry Chain Analysis
12.2 Anti-CD20 Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-CD20 Monoclonal Antibodies Production Mode & Process
12.4 Anti-CD20 Monoclonal Antibodies Sales and Marketing
12.4.1 Anti-CD20 Monoclonal Antibodies Sales Channels
12.4.2 Anti-CD20 Monoclonal Antibodies Distributors
12.5 Anti-CD20 Monoclonal Antibodies Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-CD20 Monoclonal Antibodies Industry Trends
13.2 Anti-CD20 Monoclonal Antibodies Market Drivers
13.3 Anti-CD20 Monoclonal Antibodies Market Challenges
13.4 Anti-CD20 Monoclonal Antibodies Market Restraints
14 Key Findings in The Global Anti-CD20 Monoclonal Antibodies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of First Generation Anti-CD20 Monoclonal Antibody
Table 3. Major Manufacturers of Second Generation Anti-CD20 Monoclonal Antibody
Table 4. Major Manufacturers of Third Generation Anti-CD20 Monoclonal Antibody
Table 5. Global Anti-CD20 Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Anti-CD20 Monoclonal Antibodies Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Anti-CD20 Monoclonal Antibodies Sales by Region (2017-2022) & (KG)
Table 8. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Table 9. Global Anti-CD20 Monoclonal Antibodies Sales by Region (2023-2028) & (KG)
Table 10. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2023-2028)
Table 11. Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
Table 13. Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2023-2028)
Table 15. Global Anti-CD20 Monoclonal Antibodies Sales by Manufacturers (2017-2022) & (KG)
Table 16. Global Anti-CD20 Monoclonal Antibodies Sales Share by Manufacturers (2017-2022)
Table 17. Global Anti-CD20 Monoclonal Antibodies Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
Table 19. Anti-CD20 Monoclonal Antibodies Price by Manufacturers (2017-2022) &(USD/KG)
Table 20. Global Anti-CD20 Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Anti-CD20 Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD20 Monoclonal Antibodies as of 2021)
Table 22. Anti-CD20 Monoclonal Antibodies Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Anti-CD20 Monoclonal Antibodies Product Offered
Table 24. Date of Manufacturers Enter into Anti-CD20 Monoclonal Antibodies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 27. Global Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 28. Global Anti-CD20 Monoclonal Antibodies Sales Share by Type (2017-2022)
Table 29. Global Anti-CD20 Monoclonal Antibodies Sales Share by Type (2023-2028)
Table 30. Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Type (2017-2022)
Table 33. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Type (2023-2028)
Table 34. Anti-CD20 Monoclonal Antibodies Price by Type (2017-2022) & (USD/KG)
Table 35. Global Anti-CD20 Monoclonal Antibodies Price Forecast by Type (2023-2028) & (USD/KG)
Table 36. Global Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 37. Global Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 38. Global Anti-CD20 Monoclonal Antibodies Sales Share by Application (2017-2022)
Table 39. Global Anti-CD20 Monoclonal Antibodies Sales Share by Application (2023-2028)
Table 40. Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Application (2017-2022)
Table 43. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Application (2023-2028)
Table 44. Anti-CD20 Monoclonal Antibodies Price by Application (2017-2022) & (USD/KG)
Table 45. Global Anti-CD20 Monoclonal Antibodies Price Forecast by Application (2023-2028) & (USD/KG)
Table 46. North America Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 47. North America Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 48. North America Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 51. North America Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 52. North America Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 55. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2023-2028) & (KG)
Table 56. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 59. Europe Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 60. Europe Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 63. Europe Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 64. Europe Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 67. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2023-2028) & (KG)
Table 68. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 71. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 72. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 75. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 76. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2017-2022) & (KG)
Table 79. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2023-2028) & (KG)
Table 80. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 83. Latin America Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 84. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 87. Latin America Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 88. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 91. Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2023-2028) & (KG)
Table 92. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2017-2022) & (KG)
Table 95. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Type (2023-2028) & (KG)
Table 96. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2017-2022) & (KG)
Table 99. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Application (2023-2028) & (KG)
Table 100. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2017-2022) & (KG)
Table 103. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2023-2028) & (KG)
Table 104. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 106. Genmab Corporation Information
Table 107. Genmab Description and Major Businesses
Table 108. Genmab Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 109. Genmab Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Genmab Recent Developments
Table 111. Amgen Corporation Information
Table 112. Amgen Description and Major Businesses
Table 113. Amgen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 114. Amgen Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Amgen Recent Developments
Table 116. Celltrion Corporation Information
Table 117. Celltrion Description and Major Businesses
Table 118. Celltrion Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 119. Celltrion Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Celltrion Recent Developments
Table 121. Roche Corporation Information
Table 122. Roche Description and Major Businesses
Table 123. Roche Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 124. Roche Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Roche Recent Developments
Table 126. Novartis AG Corporation Information
Table 127. Novartis AG Description and Major Businesses
Table 128. Novartis AG Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 129. Novartis AG Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Novartis AG Recent Developments
Table 131. Pfizer Corporation Information
Table 132. Pfizer Description and Major Businesses
Table 133. Pfizer Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 134. Pfizer Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Pfizer Recent Developments
Table 136. Biogen Corporation Information
Table 137. Biogen Description and Major Businesses
Table 138. Biogen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 139. Biogen Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Biogen Recent Developments
Table 141. Genentech Corporation Information
Table 142. Genentech Description and Major Businesses
Table 143. Genentech Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 144. Genentech Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Genentech Recent Developments
Table 146. Immunomedics Corporation Information
Table 147. Immunomedics Description and Major Businesses
Table 148. Immunomedics Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 149. Immunomedics Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Immunomedics Recent Developments
Table 151. Spectrum Pharmaceuticals Corporation Information
Table 152. Spectrum Pharmaceuticals Description and Major Businesses
Table 153. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 154. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Spectrum Pharmaceuticals Recent Developments
Table 156. Bio-Rad Laboratories Corporation Information
Table 157. Bio-Rad Laboratories Description and Major Businesses
Table 158. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 159. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Bio-Rad Laboratories Recent Developments
Table 161. LFB Biotechnologie Corporation Information
Table 162. LFB Biotechnologie Description and Major Businesses
Table 163. LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 164. LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. LFB Biotechnologie Recent Developments
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Anti-CD20 Monoclonal Antibodies Distributors List
Table 169. Anti-CD20 Monoclonal Antibodies Customers List
Table 170. Anti-CD20 Monoclonal Antibodies Market Trends
Table 171. Anti-CD20 Monoclonal Antibodies Market Drivers
Table 172. Anti-CD20 Monoclonal Antibodies Market Challenges
Table 173. Anti-CD20 Monoclonal Antibodies Market Restraints
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-CD20 Monoclonal Antibodies Product Picture
Figure 3. Global Anti-CD20 Monoclonal Antibodies Market Share by Type in 2021 & 2028
Figure 3. First Generation Anti-CD20 Monoclonal Antibody Product Picture
Figure 4. Second Generation Anti-CD20 Monoclonal Antibody Product Picture
Figure 5. Third Generation Anti-CD20 Monoclonal Antibody Product Picture
Figure 6. Global Anti-CD20 Monoclonal Antibodies Market Share by Application in 2021 & 2028
Figure 7. Oncology
Figure 8. Neurology
Figure 9. Immunology
Figure 10. Anti-CD20 Monoclonal Antibodies Report Years Considered
Figure 11. Global Anti-CD20 Monoclonal Antibodies Sales 2017-2028 (KG)
Figure 12. Global Anti-CD20 Monoclonal Antibodies Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Anti-CD20 Monoclonal Antibodies Revenue 2017-2028 (US$ Million)
Figure 14. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Figure 16. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2023-2028)
Figure 17. North America Anti-CD20 Monoclonal Antibodies Sales YoY (2017-2028) & (KG)
Figure 18. North America Anti-CD20 Monoclon

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antibody Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136

According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Antibody Production Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121

Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......

Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......

Global Antibody Production Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......

Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Monoclonal Antibody Industry Forecasts - China Focus

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92

This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......

Monoclonal Antibody Companies in China

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73

This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......

Monoclonal Antibody Markets in China

Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219

China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs